||Information on gliptins (sitagliptin, vildagliptin and saxagliptin) as add-on therapy with metformin or sulfonylurea for improved glycaemic control in type 2 diabetes.
|Immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinsons disease
||Information on use of immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinson's disease.
|Adrenaline autoinjector (Anapen) for acute allergic anaphylaxis
||Information about Anapen, a new adrenaline autoinjector for the emergency treatment of acute allergic anaphylaxis.
|Brief item: Paracetamol with caffeine (Panadol Extra) available over the counter from pharmacies
||Paracetamol with caffeine (Panadol Extra) available over the counter from pharmacies
|Brief item: PBS listing of extended-release pramipexole (Sifrol ER) for Parkinson's disease
||An extended-release formulation of pramipexole (Sifrol ER) has been listed on the PBS for treating Parkinson's disease.
|Brief item: Exenatide (Byetta): another new class of drugs for diabetes
||Information about exenatide (Byetta): the first incretin mimetic for use in diabetes
|Brief item: Anakinra (Kineret) to be deleted from the PBS
||Describes changes to the PBS listing of anakinra (Kineret) taking place on 1 December 2010.
|NPS RADAR August 2010
||NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.